News
Two AstraZeneca therapies accepted in Scotland
AstraZeneca has announced that Tezspire, used for severe asthma, and Forxiga, used to treat chronic heart failure, have been recommended for use within NHS Scotland by the Scottish Medicines Consortium (SMC).